Immune response to combination therapy for non-Hodgkin lymphomas.
A parametric model of tumor response to combination therapy in the presence of an immune system is described. Synergistic mechanisms which induce tumor regression are simulated with a coupled set of equations. The simulations are first compared to tumor history data obtained with a SCID mouse model...
Main Authors: | Robert F Weiss, Merlin G Miller, John F Cronin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3855741?pdf=render |
Similar Items
-
Parametric model of combination therapy for Non-Hodgkin Lymphoma.
by: Robert F Weiss, et al.
Published: (2012-01-01) -
Immune parameters as predictors of response to maintenance therapy in low grade non-Hodgkin's lymphoma patients
by: Watkins, Marcia Linda Vivienne
Published: (2018) -
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
by: Natalie S. Grover, et al.
Published: (2015-09-01) -
Cancer Immunotherapy and the Immune Response in Hodgkin Lymphoma
by: Christoph Renner, et al.
Published: (2018-06-01) -
Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors
by: Maansi Joshi, et al.
Published: (2020-01-01)